Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): The next decade

Abstract

Research on matrix metalloproteinases (MMPs) and in particular on gelatinase B, alias MMP-9, has grown exponentially in the decade 2003-2012. Structural details about flexibility of MMP-9 monomers, together with glycosylation, oligomerization, heterogeneity and instability of the wildtype enzyme explain why crystallography experiments have not yet been successful for the intact enzyme. MMP-9 may be viewed as a multidomain enzyme in which the hemopexin, the O-glycosylated and the catalytic domains yield support for attachment, articulation and catalysis, respectively. The stepwise proteolytic activation of the inactive zymogen into a catalytically active form becomes gradually better understood. Priming of activation by MMP-3 may be executed by meprins that destabilize the interaction of the aminoterminus with the third fibronectin repeat. Alternatively, autocatalytic activation may occur in the presence of molecules that tightly bind to the catalytic site and that push the cystein residue in the prodomain away from the catalytic zinc ion. Thanks to the development of degradomics technologies, substrate repertoires of MMP-9 have been defined, but it remains a challenge to determine and prove which substrates are biologically relevant. The substrate repertoire has been enlarged from extracellular to membrane-bound and efficient intracellular substrates, such as crystallins, tubulins and actins. Biological studies of MMP-9 have tuned the field from being primarily cancer-oriented towards vascular and inflammatory research. In tumor biology, it has been increasingly appreciated that MMP-9 from inflammatory cells, particularly neutrophils, co-determines prognosis and outcome. Aside from the catalytic functions executed by aminoterminal domains of MMP-9, the carboxyterminal hemopexin (PEX) domain of gelatinase B exerts non-catalytic anti-apoptotic signaling effects. The recognition that gelatinase B is induced by many pro-inflammatory cytokines, whereas its inhibitors are increased by anti-inflammatory cytokines, has generated interest to target MMP-9 in acute lethal conditions, such as bacterial meningitis, sepsis and endotoxin shock, and in acute exacerbations of chronic diseases. Previously described transcriptional regulation of MMP-9 is complemented by epigenetic checkpoints, including histone modifications and microRNAs. Because activation of proMMP-9 may be executed by other MMPs, the therapeutic dogma that MMP inhibitors need to be highly selective may be keyed down for the treatment of life-threatening conditions. When inflammation and MMP-9 fulfill beneficial functions to clear damaging protein complexes, such as in systemic autoimmune diseases, therapeutic MMP inhibition has to be avoided. In Mmp9 gene knockout mice, specific spontaneous phenotypes emerged with effects on the skeletal, reproductive and nervous systems. These findings not only have clinical correlates in bone growth and fertility, but also stimulate research on the roles of MMPs and MMP-9 in endocrinology, immunology and the neurosciences. Mm...

Identification and Characterization of Circulating Variants of CXCL12 from Human Plasma: Effects on Chemotaxis and Mobilization of Hematopoietic Stem and Progenitor Cells

“…In contrast, CXCL12 was not identified in our in vitro CXCL12-processing experiments performed with human granulocytes and was not identified in the purified material from blood filtrate, although the CXCL12[26-88]-producing protease MMP-9 is primarily expressed in granulocytes. This discrepancy may be correlated to insufficient proteolytic activation, as MMP-9 is released as an inactive zymogen [36,37]. Although human neutrophil elastase is suggested to prime activation of proMMP-9 [38], the activation of MMP-9 in the context of granulocyte activation on the hemofilter membranes may not be sufficient for the generation of FIG.…”

Niclosamide suppresses migration of hepatocellular carcinoma cells and downregulates matrix metalloproteinase-9 expression

“…MMP9 is a gelatinase involved in cancer metastasis (7). The overexpression of MMP9 is associated with the poor prognosis of cancer (8).…”

Role of Signal-Regulated Changes in Microtubule Stability Dynamics through <i>α</i>-Tubulin Phosphorylation on Ser/Tyr in Modulation of Salivary Gland Matrix Metalloproteinase-9 (MMP-9) Secretion in Response to <i>Porphyromonas gingivalis</i> and Ghrelin

“…Considering the glycoprotein nature of MMP-9 and the fact that protein glycosylation occurs mainly in the Golgi-TGN [7] [31], the above findings lend further support to the earlier data [23], suggesting that P. gingivalis exerts its effect on the acinar cell MMP-9 secretion at the level of ER-to-Golgi trafficking that requires Arf1/PKD2 participation, and that the extent of MT stabilization plays a regulatory role in the process of Arf1 Thus, our findings underscore the role of signal-regulated changes in MT stability dynamic through α-tubulin phosphorylation in controlling the salivary gland acinar cell MMP-9 secretion in response to P. gingivalis LPS as well as the modulatory influence of ghrelin. The diagram depicting the influence of P. gingivalis LPS and ghrelin on MT dynamics and the acinar cell secretion of MMP-9 is depicted in Figure 7.…”